Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

CD200 is not a reliable marker for identifying stem cells in all skin types.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

CS12192 effectively treats alopecia areata with better safety than current options.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Calancardin B may help reduce inflammation in immune cells.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

ILC1-like cells can cause alopecia areata by themselves.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.